Women in Cardiovascular Trials
Cross-source consensus on Women in Cardiovascular Trials from 1 sources and 5 claims.
1 sources · 5 claims
Risks & contraindications
Comparisons
Background
Evidence quality
Highlighted claims
- Female enrolment in major cardiovascular randomized trials increased from 21% in 1986-1990 to 33% in 2011-2015. — Sex-based and age-based differences in participation in an in-hospital atrial fibrillation screening study: a prospective cohort study in Switzerland
- Women have been persistently under-represented in cardiovascular trials. — Sex-based and age-based differences in participation in an in-hospital atrial fibrillation screening study: a prospective cohort study in Switzerland
- Female representation remained lower than expected from disease prevalence and varied by disease area. — Sex-based and age-based differences in participation in an in-hospital atrial fibrillation screening study: a prospective cohort study in Switzerland
- Lower cardiovascular disease prevalence in women does not fully explain their under-representation in cardiovascular trials. — Sex-based and age-based differences in participation in an in-hospital atrial fibrillation screening study: a prospective cohort study in Switzerland
- Trial evidence based mainly on men can reduce the strength and relevance of guideline recommendations for women. — Sex-based and age-based differences in participation in an in-hospital atrial fibrillation screening study: a prospective cohort study in Switzerland